An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression of Alzheimer’s disease in closely watched trials, Novo Nordisk…
Read more Semaglutide fails to slow progression of Alzheimer’s in highly anticipated trials, Novo Nordisk saysRite Aid Corp. said Thursday that its fiscal first-quarter pharmacy sales got a boost from a new class of drug. Pharmacy sales, which rose 3.4% from a year…
Read more Ozempic and other weight-loss drugs boost pharmacy sales at Rite AidThat’s a notion that has long fueled hope for many of the more than 40% of Americans who are considered obese — and fueled criticism by those who…
Read more No more needles? A daily pill may work as well as Wegovy shots to treat obesityMarch 6, 2023 — More than 80% of U.S. adults with type 2 diabetes meet the criteria to use new treatment drugs, such as semaglutide, which is marketed…
Read more 80% With Diabetes Eligible for New Drugs, but Cost Is a Barrier
